NL-OMON26858
Recruiting
Not Applicable
COVID-19 in rheumatic patients: a prospective cohort study
Reade Research BV0 sites8,000 target enrollmentTBD
ConditionsAll systemic autoimmune diseases
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- All systemic autoimmune diseases
- Sponsor
- Reade Research BV
- Enrollment
- 8000
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •In order to be eligible to participate in this study, a subject must meet all of the following criteria:
- •\- Age \= 18 years.
- •For patients:
- •\- Diagnosed by their treating physician with a systemic autoimmune disease.
- •For controls:
- •\- Belonging to family or close friend of patient (of the same gender).
Exclusion Criteria
- •Patients who meet the following criteria will be excluded from the study:
- •\- Language problems precluding the completion of the questionnaire;
- •\- Likelihood of absence in the next 6 months;
- •\- Lack of informed consent.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Not Applicable
Hydroxy Chloroquine and Covid in RA PatientsCOVIDNCT04471649Tanta University80
Completed
Not Applicable
Prognostic Evaluation of COVID-19 in Rheumatoid Arthritis PatientsCovid19Rheumatoid ArthritisNCT04679272University Hospital, Montpellier2,000
Unknown
Not Applicable
Predictive Factors for COVID-19 in RheumatologyRheumatic DiseasesCovid19NCT04567576Fundación Santa Fe de Bogota150
Withdrawn
Not Applicable
Anti-rheumatic Drug Use and Risk of COVID-19 Infection in Rheumatoid Arthritis PatientsRheumatoid ArthritisCOVIDNCT04434118Sadat City University
Terminated
Not Applicable
Morbimortality of Covid-19 in Patients With Chronic Inflammatory Rheumatism Treated With ImmunosuppressantsSars-CoV2Rheumatoid ArthritisRheumatic DiseasesNCT04426279University Hospital, Lille539